Efficacy and safety of different antidepressants and anticonvulsants in central poststroke pain: A network meta-analysis and systematic review

<h4>Objective</h4> To evaluate the efficacy and safety of different antidepressants and anticonvulsants in the treatment of central poststroke pain (CPSP) by network meta-analysis and provide an evidence-based foundation for clinical practice. <h4>Methods</h4> PubMed, Cochran...

Full description

Bibliographic Details
Main Authors: Ke-Yu Chen, Ruo-Yang Li
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9560062/?tool=EBI
_version_ 1817984088387092480
author Ke-Yu Chen
Ruo-Yang Li
author_facet Ke-Yu Chen
Ruo-Yang Li
author_sort Ke-Yu Chen
collection DOAJ
description <h4>Objective</h4> To evaluate the efficacy and safety of different antidepressants and anticonvulsants in the treatment of central poststroke pain (CPSP) by network meta-analysis and provide an evidence-based foundation for clinical practice. <h4>Methods</h4> PubMed, Cochrane Library, EMBASE, CNKI, APA PsycINFO, Wanfang, VIP and other databases were searched by computer to find clinical randomized controlled studies (RCTs) on drug treatment of CPSP. The retrieval time limit was from the establishment of each database to July 2022. The quality of the included RCTs was evaluated using the bias risk assessment tool recommended by Cochrane. Stata 14.0 was used for network meta-analysis. <h4>Results</h4> A total of 13 RCTs, 1040 patients and 9 drugs were finally included. The results of the network meta-analysis showed that the effectiveness ranking as rated by the visual analog scale (VAS) was gabapentin > pregabalin > fluoxetine > lamotrigine > duloxetine > serqulin > amitriptyline > carbamazepine > vitamin B. Ranking according to the numerical rating scale (NRS) was pregabalin > gabapentin > carbamazepine. Ranking derived from the Hamilton depression scale (HAMD) was pregabalin > duloxetine > gabapentin > amitriptyline. <h4>Conclusion</h4> All nine drugs can relieve the pain of CPSP patients to different degrees; among them pregabalin and gabapentin have the most significant effect, and gabapentin and pregabalin also have the most adverse reactions. In the future, more multicenter, large sample, double-blind clinical randomized controlled trials need to be carried out to supplement and demonstrate the results of this study.
first_indexed 2024-04-13T23:41:11Z
format Article
id doaj.art-df3e88c1e0dd47babf4506fa38df5c37
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-13T23:41:11Z
publishDate 2022-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-df3e88c1e0dd47babf4506fa38df5c372022-12-22T02:24:31ZengPublic Library of Science (PLoS)PLoS ONE1932-62032022-01-011710Efficacy and safety of different antidepressants and anticonvulsants in central poststroke pain: A network meta-analysis and systematic reviewKe-Yu ChenRuo-Yang Li<h4>Objective</h4> To evaluate the efficacy and safety of different antidepressants and anticonvulsants in the treatment of central poststroke pain (CPSP) by network meta-analysis and provide an evidence-based foundation for clinical practice. <h4>Methods</h4> PubMed, Cochrane Library, EMBASE, CNKI, APA PsycINFO, Wanfang, VIP and other databases were searched by computer to find clinical randomized controlled studies (RCTs) on drug treatment of CPSP. The retrieval time limit was from the establishment of each database to July 2022. The quality of the included RCTs was evaluated using the bias risk assessment tool recommended by Cochrane. Stata 14.0 was used for network meta-analysis. <h4>Results</h4> A total of 13 RCTs, 1040 patients and 9 drugs were finally included. The results of the network meta-analysis showed that the effectiveness ranking as rated by the visual analog scale (VAS) was gabapentin > pregabalin > fluoxetine > lamotrigine > duloxetine > serqulin > amitriptyline > carbamazepine > vitamin B. Ranking according to the numerical rating scale (NRS) was pregabalin > gabapentin > carbamazepine. Ranking derived from the Hamilton depression scale (HAMD) was pregabalin > duloxetine > gabapentin > amitriptyline. <h4>Conclusion</h4> All nine drugs can relieve the pain of CPSP patients to different degrees; among them pregabalin and gabapentin have the most significant effect, and gabapentin and pregabalin also have the most adverse reactions. In the future, more multicenter, large sample, double-blind clinical randomized controlled trials need to be carried out to supplement and demonstrate the results of this study.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9560062/?tool=EBI
spellingShingle Ke-Yu Chen
Ruo-Yang Li
Efficacy and safety of different antidepressants and anticonvulsants in central poststroke pain: A network meta-analysis and systematic review
PLoS ONE
title Efficacy and safety of different antidepressants and anticonvulsants in central poststroke pain: A network meta-analysis and systematic review
title_full Efficacy and safety of different antidepressants and anticonvulsants in central poststroke pain: A network meta-analysis and systematic review
title_fullStr Efficacy and safety of different antidepressants and anticonvulsants in central poststroke pain: A network meta-analysis and systematic review
title_full_unstemmed Efficacy and safety of different antidepressants and anticonvulsants in central poststroke pain: A network meta-analysis and systematic review
title_short Efficacy and safety of different antidepressants and anticonvulsants in central poststroke pain: A network meta-analysis and systematic review
title_sort efficacy and safety of different antidepressants and anticonvulsants in central poststroke pain a network meta analysis and systematic review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9560062/?tool=EBI
work_keys_str_mv AT keyuchen efficacyandsafetyofdifferentantidepressantsandanticonvulsantsincentralpoststrokepainanetworkmetaanalysisandsystematicreview
AT ruoyangli efficacyandsafetyofdifferentantidepressantsandanticonvulsantsincentralpoststrokepainanetworkmetaanalysisandsystematicreview